Related Experiment Video

Updated: Mar 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity

Koji Nomura1, Marta Klejnot1, Dominika Kowalczyk1

  • 1Cancer Research-UK Beatson Institute, Garscube Estate, Glasgow, UK.

Nature Structural & Molecular Biology
|May 30, 2017
PubMed

Insights

Researchers designed MDM2 mutants to disrupt E3 ligase activity, potentially improving cancer therapy. This approach aims to activate the p53 tumor suppressor in cancer cells while minimizing toxicity in normal tissues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MDM2-MDMX complexes inhibit the p53 tumor suppressor by blocking its activity and promoting degradation.
  • Targeting MDM2-MDMX interactions activates p53 but can cause on-target toxicities in normal tissues.
  • Wild-type p53 is crucial for tumor suppression, making its activation a therapeutic goal.

Purpose of the Study:

  • To design MDM2 mutants that inhibit E3 ligase activity without affecting the RING-domain structure.
  • To assess the therapeutic potential of targeting MDM2's E3 ligase function for cancer treatment.
  • To evaluate the impact of these mutants on p53 activity and cellular response to stress.

Main Methods:

  • Utilized a crystal structure of the MDM2-MDMX-E2(UbcH5B)-ubiquitin complex to guide mutant design.
  • Created MDM2 mutants lacking E3 ubiquitin ligase activity.
  • Assessed p53 transcriptional activity, cell proliferation, and cellular stress response in cells expressing wild-type vs. mutant MDM2.

Main Results:

  • Developed MDM2 mutants that prevent E2-ubiquitin binding, thus lacking E3 ligase activity.
  • These mutants maintained the ability to limit p53 transcriptional activity and support cell proliferation.
  • Cells with MDM2 mutants showed a faster response to cellular stress while preserving basal p53 control.

Conclusions:

  • Targeting MDM2's E3 ligase activity offers a strategy to widen the therapeutic window for p53 activation in tumors.
  • MDM2 mutants provide a potential approach to selectively activate p53 in cancer cells, reducing systemic toxicity.
  • This research opens new avenues for developing safer and more effective cancer therapies by modulating the p53 pathway.

More Related Videos

CD Spectroscopy to Study DNA-Protein Interactions06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

7.7K
Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.8K